Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2012
11/29/2012US20120304319 Tox3 as a biomarker for breast cancer
11/29/2012US20120304318 Cancer diagnosis and treatment
11/29/2012US20120303472 Methods for placing, accepting, and filling orders for products and services
11/29/2012US20120302940 Popcorn Shape Gold Nanoparticle For Targeted Diagnosis, Photothermal Treatment and In-Situ Monitoring Therapy Response for Cancer and Multiple Drug Resistance Bacteria
11/29/2012US20120302741 Non-invasive detection of fetal genetic traits
11/29/2012US20120302649 Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302626 Microrna and use thereof in identification of b cell malignancies
11/29/2012US20120302624 Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
11/29/2012US20120302595 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
11/29/2012US20120302517 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms
11/29/2012US20120302509 Compositions and methods to prevent cancer with cupredoxins
11/29/2012US20120302464 Methods for producing recombinant proteins
11/29/2012US20120302460 Use of Low Affinity Neurotrophin Receptor P75 As Marker for High Differentiation Potential Muscle Stem Cells, Muscle Satellite Cells, And Degenerative Skeletal Muscle Diseases
11/29/2012US20120302453 Oxocarbonamide peptide nucleic acids and methods of using same
11/29/2012US20120302452 Comparative ligand mapping from mhc class i positive cells
11/29/2012US20120302451 Compositions and methods for gene signature-based chemical screening
11/29/2012US20120302449 Chromosome Conformation Analysis
11/29/2012US20120301959 Cryoconserved Mature Dendritic Cells
11/29/2012US20120301915 System and automated device for analysing a cell suspension
11/29/2012US20120301914 High Resolution Label-Free Sensor
11/29/2012US20120301912 Methods, compositions and kits for assaying mitochondrial function
11/29/2012US20120301909 Sulfotransferase assay
11/29/2012US20120301908 Method for Determining the Reliability of a Device for Measuring the Concentration of a Substance in Whole Blood, Method for Treating Whole Blood, Container and Kit
11/29/2012US20120301892 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
11/29/2012US20120301891 Biomarkers of cancer metastasis
11/29/2012US20120301890 Methods for identifying nucleic acid ligands
11/29/2012US20120301889 Method and reagents for identifying pluripotent stem cells
11/29/2012US20120301888 Nmr systems and methods for the rapid detection of analytes
11/29/2012US20120301887 Gene Expression Profiling for the Identification, Monitoring, and Treatment of Prostate Cancer
11/29/2012US20120301886 Polytag probes
11/29/2012US20120301885 Cytogenic analysis of metaphase chromosomes
11/29/2012US20120301883 Sheath flow devices and methods
11/29/2012US20120301882 Methods for generating databases and databases for identifying polymorphic genetic markers
11/29/2012US20120301881 Compositions, Methods and Related Uses for Cleaving Modified DNA
11/29/2012US20120301879 Novel use of ca-125
11/29/2012US20120301878 Methods and compositions for the detection of drug resistant braf isoforms
11/29/2012US20120301877 Use of Phenanthridium Derivatives for Distinguishing Between Intact and Membrane Comprised Cells Using Molecular Nucleic Acid-Based Techniques
11/29/2012US20120301876 Method to quantify sirnas, mirnas and polymorphic mirnas
11/29/2012US20120301875 Amplicon melting analysis with saturation dyes
11/29/2012US20120301874 Compositions and Methods for Detection of Staphylococcus Aureus
11/29/2012US20120301871 Comparative ligand mapping from mhc positive cells
11/29/2012US20120301870 Enhanced Stability of Proteins Immobilized on Nanoparticles
11/29/2012US20120301575 Bacterium
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301475 Novel heparanase splice variant
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301438 Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells
11/29/2012US20120301437 Technologies, Methods, and Products of Small Molecule Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells
11/29/2012US20120301435 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/29/2012US20120301428 Clostridium gene
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301402 Rap1a as a marker for cardiac arrhythmia
11/29/2012DE602004036672C5 Nukleinsäureamplifikation auf Basis von Kügelchenemulsion Nucleic acid amplification-based emulsion globules
11/29/2012DE102012003700B3 Verfahren zur Trennung von Verbänden maligner Zellen und Verbänden aus Stromazellen einer Malignomgewebeprobe Process for the separation of associations of malignant cells and stromal associations from a Malignomgewebeprobe
11/29/2012DE102009058634B4 Toxizitätstest Toxicity test
11/29/2012CA2839794A1 Selective ultrasonic lysis of blood and other biological fluids and tissues
11/29/2012CA2836940A1 Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
11/29/2012CA2836844A1 Biomarkers for lung cancer
11/29/2012CA2836774A1 Analysis and sorting of motile cells
11/29/2012CA2836711A1 Bilirubin oxidase from magnaporthe oryzae and applications thereof
11/29/2012CA2836538A1 Clozapine immunoassay
11/29/2012CA2836494A1 Individualized vaccines for cancer
11/29/2012CA2835834A1 Salmonella detection articles and methods of use
11/29/2012CA2835170A1 Development of phytophthora resistant potato with increased yield
11/29/2012CA2834660A1 Universal primers and the use thereof for the detection and identification of amphibia/fish species
11/29/2012CA2834442A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2834440A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2831182A1 Compositions and methods for detection of staphylococcus aureus
11/29/2012CA2829035A1 Analyzing the fmr1 gene
11/28/2012EP2527838A2 Methods and reagents for detecting susceptibility to transplant related mortality (TRM)
11/28/2012EP2527501A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
11/28/2012EP2527475A1 Primers for detecting plasmodium
11/28/2012EP2527474A1 Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
11/28/2012EP2527473A2 B cell signature associated with tolerance in transplant recipients
11/28/2012EP2527472A2 A genetic lesion associated with cancer
11/28/2012EP2527471A2 Diagnosing cancer using genomic sequencing
11/28/2012EP2527470A2 Nucleic acid amplification and testing
11/28/2012EP2527469A1 Dry reagent, dry reagent kit, reagent container, and method for producing dry reagent
11/28/2012EP2527468A1 Amplicon melting analysis with saturation dyes
11/28/2012EP2527467A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
11/28/2012EP2527466A2 Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
11/28/2012EP2527465A2 Nucleic acids probes for detection of yeast and fungal species
11/28/2012EP2527464A2 Nucleic acids probes for detection of yeast and fungal species
11/28/2012EP2527463A2 Nucleic acids probes for detection of yeast and fungal species
11/28/2012EP2527462A2 Nucleic acids probes for detection of yeast and fungal species
11/28/2012EP2527461A2 Nucleic acids probes for detection of yeast and fungal species
11/28/2012EP2527460A1 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
11/28/2012EP2527459A1 Blood-based gene detection of non-small cell lung cancer
11/28/2012EP2527458A2 Methods and reagents for detecting susceptilbility to graft versus host disease
11/28/2012EP2527447A1 Agents and methods for diagnosing stress
11/28/2012EP2527446A1 Agents and methods for diagnosing stress
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527441A2 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
11/28/2012EP2527434A1 Probe reagent for measurement of protein decomposition activity
11/28/2012EP2527422A1 Apparatus for trapping floating bacterial cells, method for counting floating bacterial cells, and system for counting floating bacterial cells
11/28/2012EP2526970A1 Monitoring cancer stem cells
11/28/2012EP2526969A1 Monitoring cancer stem cells
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 3003